Migraines - Xconomy

by in

Entry	Author	Date	Location
Alder Biopharma Looks to Take On Migraines, and the World	Luke Timmerman	01/24/13	Seattle
In a Detour From Device Strategy, Zogenix Edges Closer to New Drug Application	Bruce V. Bigelow	10/27/11	San Diego
Zogenix Files for IPO, Orexigen Licenses Obesity Drug to Takeda, ImThera Raises Capital For Sleep Apnea, & More San Diego Life Science News	Bruce V. Bigelow	09/09/10	San Diego
San Diego’s Zogenix Files for $90M IPO to Expand Development of Needle-Free Injector and Pain Drugs	Bruce V. Bigelow	09/07/10	San Diego
San Diego’s Zogenix Moving Fast to Commercialize Drug-and-Device Combo	Bruce V. Bigelow	08/17/10	San Diego
With Extra Dose of Cash, Zogenix Raises VC Round to $71M for Launch of Migraine Treatment	Bruce V. Bigelow	12/08/09	San Diego
Investors Inject $51M B Round into Zogenix to Combat Migraines	Ryan McBride	09/24/09	San Diego
And Then There Were 3 at TorreyPines Therapeutics	Juha-Pekka Tikka	04/01/09	San Diego
Page 1 of 1

Xconomy National